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Valve-in-Valve and Pulmonary Valve
ImplantationPatients with surgically treated congenital cardiac
disease increasingly survive into adulthood and face
the need for repeat sternotomies for senescent pros-
thetic valves and conduits. This poses increased risk
of chest re-entry injury, and alternatives to redo
median sternotomy are important. Although trans-
catheter aortic valve-in-valve (ViV) and transcatheter
pulmonary valve implantation (TPVI) (Melody valve,
Medtronic, Minneapolis, Minnesota) have both been
separately described (1–3), we describe a combination
of aortic ViV and TPVI utilizing 3-dimensional (3D)
computed tomography (CT) ﬂuoroscopic coregistra-
tion to aid procedural execution. A 24-year-old man
with congenital bicuspid aortic stenosis, prior Ross
procedure, re-replacement of the right ventricle–
pulmonary artery homograft, ascending aortic aneu-
rysm repair, and aortic valve replacement (25-mm
Perimount bioprosthesis, Edwards Lifesciences,
Irvine, California) was referred for symptomatic
aortic and pulmonary conduit stenoses. Aortic valve
mean gradient was 52 mm Hg, and mean pulmonary
conduit gradient was 38 mm Hg. CT demonstrated
pulmonary conduit stenosis and an aortic annular
area of 360 mm2 (annular dimensions 21.9 mm 
21.5 mm). The distances of the right coronaryartery origin and proximal left anterior descending
artery from the pulmonary artery were 8.7 mm and
11.9 mm, respectively. Coronary artery relational
anatomy was felt to be favorable for intervention
with combined transcatheter aortic ViV and TPVI
(Figure 1A).
Using standard techniques, a 26-mm transcatheter
aortic valve replacement (Sapien-XT, Edwards Life-
sciences) was successfully undertaken within the
aortic prosthesis. Post-deployment echocardiographic
assessment demonstrated normal valve function. A
noncontrast rotational angiogram of the cardiac and
vascular structures was then performed, and images
were matched with previously performed CT re-
constructions of the pulmonary conduit. Coregistra-
tion using known skeletal landmarks enabled overlay
of 3D images onto live ﬂuoroscopy to guide trans-
catheter pulmonary valve placement. An exchange-
length stiff guidewire was placed in the left lower
lobe pulmonary artery using a balloon wedge catheter,
and serial balloon dilations of the pulmonary conduit
were performed using 18- and 22-mm balloons with
simultaneous left coronary angiography demon-
strating no coronary–conduit interaction. A 22-mm
diameter balloon-in-balloon “BIB” catheter (NuMed,
Hopkinton, New Jersey) with a mounted stent (Pal-
maz-XL-4010, Cordis, Bridgewater, New Jersey) was
delivered via a 14-Fr Mullins sheath into the pulmo-
nary conduit. This was used to expand the homograft
conduit and prepare a landing zone to minimize future
risk of transcatheter pulmonary valve stent fracture.
Fluoroscopic and 3D CT overlay facilitated accurate
positioning and deployment of the stent. The stentwas
then post-dilated using a 22-mm balloon, and no stent
recoil was noted. A 22-mm transcatheter pulmonary
valve was then successfully deployed using a 22-mm
delivery system (Ensemble delivery system, Med-
tronic) within the landing zone created by the stent
(Figures 1B and 1C). The peak-to-peak catheter right
ventricular outﬂow tract (RVOT) gradient was reduced
to 5 mm Hg. Transesophageal echocardiography
showed normal valve function with mild regurgita-
tion. The patient was dismissed from the hospital on
day 2 with a mean transaortic gradient of 21 mm Hg,
and 11 mm Hg across the RVOT, with no demonstrable
regurgitation.
This presentation is unique in that this was a young
adult with 3 previous median sternotomies within a
period of 6 years, and efforts to avoid a repeated me-
dian sternotomy were critical. Multidisciplinary
assessment and 3D imaging were essential to proce-
dural planning and execution. Although annular
calciﬁcation and radiographic signatures of prosthetic
valves can often serve as ﬂuoroscopic markers and
FIGURE 1 Pre- and Post-Intervention 3D Surface-Rendered Images of Aortic and Pulmonary Outﬂow Tracts
(A) Surface-rendered images of the aorta (Ao) and right ventricular outﬂow tract (RVOT) demonstrating favorable relational anatomy of
reimplanted coronary buttons to the RVOT/main pulmonary artery (MPA). The inset shows a distance ofw8.8 mm between the RVOT and right
coronary artery. (B) Lateral projection with ﬂuoroscopic overlay during inﬂation of the outer balloon for delivery of transcatheter pulmonary
valve (red arrow); transcatheter aortic valve in aortic position (blue arrow). (C) Final surface 3-dimensional (3D) rendered image of the
transcatheter aortic and pulmonary valves. PV ¼ pulmonary vein; RCA ¼ right coronary artery.
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867assist with valve positioning and deployment during
transcatheter valve–ViV implantation, these are not
always available or optimal for procedural guidance.
The use of 3D CT ﬂuoroscopic coregistration using
skeletal landmarks can signiﬁcantly improve the ac-
curacy of valve positioning and procedural success.Saurabh Sanon, MD
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Pushing the Limits of Spatial ResolutionWe read with interest the paper by Park et al. (1)
concerning the association between certain athero-
sclerotic plaque characteristics (APCs), depicted by
coronary computed tomography angiography (CTA)
and the presence of ischemia by invasive frac-
tional ﬂow reserve (FFR). The study addressed the
